96851 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
COMPOUNDS AND METHODS FOR IMMUNOTHERAPY AND DIAGNOSIS OF TUBERCULOSIS
#302Aldehyde tags, uses thereof in site-specific protein modification
#303Multivalent vaccines comprising recombinant viral vectors
#304TUBERCULOSIS ANTIGEN DETECTION ASSAYS AND VACCINES
#305Method of Diagnosis of Infection by Mycobacteria and Reagents Therefor
#306Conjugates that contain the homeodomain of antennapedia
#307Multivalent vaccines comprising recombinant viral vectors
#308MARA FAMILY HELIX-TURN-HELIX DOMAINS AND THEIR METHODS OF USE
#309Aldehyde tags, uses thereof in site-specific protein modification
#310Lentiviral vectors for the preparation of immunotherapeutical compositions
#311Compositions and methods
#312Tuberculosis vaccines comprising antigens expressed during the latent infection phase
#313TUBERCULOSIS RV2386C PROTEIN, COMPOSITIONS AND USES THEREOF
#314Tuberculosis diagnostic test
#315Antigens for paratuberculosis diagnosis and vaccination
#316COMPOSITIONS AND METHODS FOR MAKING ANDROSTENEDIONES
#317Cattle vaccines
#318Constructing a DNA chimera for vaccine development against leishmaniasis and tuberculosis
#319COMPOUNDS AND METHODS FOR DIAGNOSIS AND IMMUNOTHERAPY OF TUBERCULOSIS
#320Immunogenic constructs
#321Immunotherapies employing self-assembling vaccines
#322Recombinant BCG tuberculosis vaccine designed to elicit immune responses to mycobacterium tuberculosis in all physiological stages of infection and disease
#323NOVEL COMPOSITIONS AND METHODS
#324Immunodominant peptides from cell wall proteins for early diagnosis and immunization
#325MYCOBACTERIAL GENES DOWN-REGULATED DURING LATENCY
#326PCR-BASED GENOTYPING
#327PROTEINS EXPRESSED BY MYCOBACTERIUM TUBERCULOSIS AND NOT BY BCG AND THEIR USE AS VACCINES
#328Biological materials and uses thereof
#329Anti-atheroma vaccine
#330Assay for antibodies to
#331Therapeutic TB vaccine
#332Methods for producing an immune response to tuberculosis
#333Immunogenic polypeptide isolated from subspecies and uses thereof
#334antigens
#335Immunogenic compositions against tuberculosis
#336Transmission using nested OFDMA
#337Mycobacterial mutants affecting host apoptosis
#338MARA FAMILY HELIX-TURN-HELIX DOMAINS AND THEIR METHODS OF USE
#339Replikin peptides in rapid replication of glioma cells and in influenza epidemics
#340Anti-cancer DNA vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
#341System and method for identifying complex patterns of amino acids
#342PROCESS FOR OBTAINING BIOACTIVE RECOMBINANT PROTEIN FROM INCLUSION BODIES
#343Modulation of Gamma-Delta T Cells to Regulate Airway Hyperresponsiveness
#344Engineered antibody-stress protein fusions
#345REPLIKINS AND METHODS OF IDENTIFYING REPLIKIN-CONTAINING SEQUENCES
#346USE OF THE PROTIEN MABA (FABG1) OF MYCOBACTERIUM TUBERCULOSIS FOR DESIGNING AND SCREENING ANTIBIOTICS
#347REPLIKIN PEPTIDES AND ANTIBODIES THEREFOR
#348Assay method for peptide specific T-cells
#349Fusion proteins of mycobacterium tuberculosis
#350Fusion proteins of
#351fusion protein and uses thereof
#352Heat shock proteins from and uses thereof
#353Immunogenic compositions comprising polypeptides and fusions thereof
#354INHIBITORS OF FTSZ AND USES THEREOF
#355TUBERCULOSIS NUCLEIC ACIDS, POLYPEPTIDES AND IMMUNOGENIC COMPOSITIONS
#356Compositions and methods to prevent cancer with cupredoxins
#357Poly TLR antagonist
#358NOVEL METHOD AND COMPOSITIONS
#359Tuberculosis diagnostic test
#360IN VIVO CTL ELICITATION BY HEAT SHOCK PROTEIN FUSION PROTEINS MAPS TO A DISCRETE DOMAIN AND IS CD4+ T CELL-INDEPENDENT
#361Proteins expressed by and not by BCG and their use as diagnostic reagents and vaccines
#362Fusion proteins of mycobacterium tuberculosis
#363Targeting of long chain triacylglycerol hydrolase gene for tuberculosis treatment
#364Methods for detecting a infection
#365Compounds and methods for immunotherapy and diagnosis of tuberculosis
#366Fusion proteins of
#367Compositions and methods for determining immune status
#368Bacterial ATP synthase binding domain
#369REPLIKIN PEPTIDES IN RAPID REPLICATION OF GLIOMA CELLS AND IN INFLUENZA EPIDEMICS
#370MEANS AND METHODS FOR MANIPULATING SEQUENTIAL PHAGOLYSOMALCYTOSOLIC TRANSLOCATION OF MYCOBACTERIA, AND USES THEREOF
#371Immunogenic constructs
#372Methods to treat cancer with cupredoxins
#373Replikin peptides in rapid replication of glioma cells and in influenza epidemics
#374Tuberculosis vaccines comprising antigens expressed during the latent infection phase
#375B-cell epitope peptides of HSP 65, novel amino acid sequences, DNA encoding the amino acid sequences of said peptides, antibodies directed against said peptides and different uses thereof in the treatment of inflammatory and autoimmune diseases
#376Mesothelin antibody protein fusions and methods of use
#377REPLIKIN PEPTIDES AND ANTIBODIES THEREFORE
#378Cytotoxic factors for modulating cell death
#379Recombinant BCG tuberculosis vaccine designed to elicit immune responses to in all physiological stages of infection and disease
#380Nucleic acid-like proteins
#381Methods for producing an immune response to tuberculosis
#382Generation of new BCG vaccine strains protecting against the establishment of latent infection and reactivation from the latent or persistent state
#383Method for preventing or treating infection
#384Multivalent vaccines comprising recombinant viral vectors
#385Compositions for eliciting an immune response against subspecies
#386Mycobacterial antigens expressed during latency
#387Immunogenic compositions and methods
#388Engineered antibody-stress protein fusions
#389Mycobacterial antigens expressed under low oxygen tension
#390Compounds and methods for diagnosis and immunotherapy of tuberculosis
#391Fusion proteins of mycobacterium tuberculosis
#392Compounds and methods for immunotherapy and diagnosis of tuberculosis
#393Methods of Diagnosis and Treatment of M.Tuberculosis Infection and Reagents Therefor
#394Fusion proteins of mycobacterium tuberculosis
#395Conjugates that contain the homeodomain of antennapedia
#396Fusion proteins of mycobacterium tuberculosis
#397Compositions and methods for treating malaria with cupredoxin and cytochrome
#398Compositions and methods for treating malaria with cupredoxin and cytochrome
#399Replikins and methods of identifying replikin-containing sequences
#400Fusion proteins of
#401TB diagnostic based on antigens from
#402Fusion proteins of
#403Immunogenic glycopeptides, screening, preparation and uses
#404Bacterial pheromones and uses thereof
#405Compounds and methods for immunotherapy and diagnosis of tuberculosis
#406Aldehyde tags, uses thereof in site-specific protein modification
#407Compounds and methods for diagnosis and immunotherapy of tuberculosis
#408Biomarkers of tuberculosis that distinguish disease categories: use as serodiagnostic antigens
#409Fusion proteins of Mycobacterium tuberculosis
#410SELECTION METHOD OF PEPTIDES, PEPTIDES, METHOD AND KIT OF INFECTION IDENTIFICATION BY MYCOBACTERIUM LEPRAE, PHARMACEUTICAL OR IMMUNOLOGICAL COMPOSITIONS CONTAINING PEPTIDES OF MYCOBACTERIUM LEPRAE OR SEQUENCES FUNCTIONALLY EQUIVALENT
#411Compositions and methods to prevent cancer with cupredoxins
#412ASSAY FOR ANTIBODIES TO MYCOBACTERIUM PARATUBERCULOSIS
#413Pili from
#414Antigenic peptides
#415IMMUNE RESPONSES AGAINST HPV ANTIGENS ELICITED BY COMPOSITIONS COMPRISING AN HPV ANTIGEN AND A STRESS PROTEIN OR AN EXPRESSION VECTOR CAPABLE OF EXPRESSION OF THESE PROTEINS
#416Compositions and methods for detecting multidrug resistant strains of M. tuberculosis having mutations in genes of the mutT family
#417Ligand-dependent protein splicing
#418Virulence genes of M. marinum and M. tuberculosis
#419Proteins expressed by and not by BCG and their use as diagnostic reagents and vaccines
#420Proteins expressed by and not by BCG and their use as diagnostic reagents and vaccines
#421Immune diagnostic assay to diagnose and monitor tuberculosis infection
#422Fusion proteins of
#423TB diagnostic based on antigens from M. tuberculosis
#424Targeting of long chain triacylglycerol hydrolase gene for tuberculosis treatment
#425Heat shock proteins from and uses thereof
#426Immune responses using compositions containing stress proteins
#427Compound and methods for diagnosis of tuberculosis
#428Tuberculosis vaccine with improved efficacy
#429Cytotoxic factors for modulating cell death
#430Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library: application to the detection of mycobacteria
#431Iontophoresis apparatus and method for the diagnosis of tuberculosis
#432Compounds and methods for diagnosis and immunotherapy of tuberculosis
#433Replikin peptides in rapid replication of glioma cells and in influenza epidemics
#434Tuberculosis antigen detection assays and vaccines
#435Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds
#436Virulence genes of M.marinum and M. tuberculosis
#437Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
#438METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF VIRAL AND BACTERIAL INFECTIONS
#439Modified ESAT-6 molecules and improved vaccine strains of BCG
#44032-kDa protein derived from and related peptides
#441Fusion proteins of antigens and their uses
#442Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same
#443Diagnosis and treatment of microbacterial infections
#444Use of heat shock proteins
#445Compositions and methods for treating malaria with cupredoxin and cytochrome
#446Desaturase antigen of Mycobacterium tuberculosis
#447Inhibitors of FtsZ and uses thereof
#448Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof
#449Annotation of genome sequences
#450Immunogenic polypeptide isolated from mycobacterium avium subspecies paratuberculosis and uses thereof
#451Vector carrying a polynucleotide which encodes a GSD polypeptide from Mycobacterium paratuberculosis
#452Fusion proteins of
#453Abundant extracellular products and methods for their production and use
#454Stress proteins and uses therefor
#455Stress proteins and uses therefor
#456Fusion proteins of mycobacterium tuberculosis
#457Antigenic peptides
#458Tuberculosis nucleic acids, polypeptides and immunogenic compositions
#459Antibodies that bind polypeptides
#460Delete sequence in , method for detecting mycobacteria using these sequences and vaccines
#461Specific epitope based immunological diagnosis of tuberculosis
#462Composition comprising a protein encoded by a modified ERP gene of
#463Method of dna testing for mycobacterium paratuberculosis strains
#464Process for producing a recombinant protein in a mycobacterium host plasmid pJAM2
#465Hla binding peptides and their uses
#466Antigen ORF Rv2430c and a method thereof
#467Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library: application to the detection of mycobacteria
#468Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins
#469epitopes and methods of use thereof
#470Stress proteins and peptides and methods of use thereof
#471Use of the protein maba (fabg1) of mycobacterium tuberculosis for designing and screening antibiotics
#472Fusion proteins of mycobacterium tuberculosis antigens and their uses
#473System and method for identifying complex patterns of amino acids
#474Recombinant ESAT-6:CFP-10 fusion protein useful for specific diagnosis of tuberculosis
#475Ligand-dependent protein splicing
#476Compositions and methods for treatment of infectious and inflammatory diseases
#477Attenuated vaccines
#478Method for detecting mycobacteria using deleted sequences in BCG/or tuberculosis
#479Method for isolating a polynucleotide of interest from the genome of a using a BAC-based DNA library. application to the detection of mycobacteria
#480Method of screening anti-mycobacterial molecules
#481Paramycobacterial diagnostics and vaccines
#482Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of BCG and
#483Process for identifying a novel target for use for the development of therapeutic modalities and drugs effective against tuberculosis
#484Compositions isolated from M. vaccae and their use in the modulation of immune responses
#485Immune responses using compositions containing stress proteins
#486Compounds and methods for diagnosis of tuberculosis
#487Probiotic propionibacterium
#488Method and composition
#489Stress proteins and uses therefor
#490Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
#491Hepatitis B virus treatment
#492Compounds and methods for immunotherapy and diagnosis of tuberculosis
#493B-cell epitope peptides of HSP 65, DNA encoding said peptides, antibodies directed against said peptides and the different uses thereof in the treatment of inflammatory and autoimmune diseases
#494Reduction in the virulence of and protection against tuberculosis by means of gene inactivation
#495Amino acid sequences, DNA encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
#496Promoter for high-throughput screening for inhibitors against Mycobacteria under low carbon conditions
#497Induction of a Th1-like response in vitro
#498Expression of membrane proteins using an adenylyl cyclase of mycobacterium tube rculosis
#499Vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete domain and is CD4+ T cell-independent
#500Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
#501Method of screening anti-mycobacterial molecules
#502Compositions and methods for detecting multidrug resistant strains of M. tuberculosis having mutations in genes of the mutT family
#503Modulation of gamma delta T cells to regulate airway hyperresponsiveness